Oxcarbazepine
- Product NDC
- 67877-532
- 11-digit product format
- 678770532
- Labeler code
- 67877
- Product ID
- 67877-532_1f629ae0-1f1c-4bce-b216-af26d84d24c6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxcarbazepine
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA213183
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Substance
- OXCARBAZEPINE
- Active strength
- 60 mg/mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oxcarbazepine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXCARBAZEPINE | 60 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VZI5B1W380 |
| Rxcui | 283536 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67877-532-58 | Oxcarbazepine | 250 mL in 1 BOTTLE | SUSPENSION | 250 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67877-532 | OXCARBAZEPINE SUSPENSION [ASCEND LABORATORIES, LLC] | 5 | Current NDC, 1 package rows | 20250228_3f36f519-c30c-4929-afa0-9844dc531e3f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67877-532-58 | 67877053258 | 250 mL in 1 BOTTLE (67877-532-58) | 250 ml | 2020-01-01 | No | No | Current |